Skip to main content
Antiretroviral treatment simplification with two-drug regimens: Impact of transmitted drug resistance mutations
Published Web Location
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942491/No data is associated with this publication.
Abstract
The frequency of clinically relevant transmitted drug resistance mutations (DRMs) against drugs used for 2-drug regimens was 15.6%, but only 2% were not eligible for 1 or more 2-drug regimens. More than 50% of patients harboring any clinically relevant DRMs were found to be part of genetic transmission clusters.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.